Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF

PURPOSE: Can relugolix, a novel oral gonadotropin‐releasing hormone receptor (GnRH) antagonist, function as an alternative ovulation inhibitor to GnRH antagonist injections? METHODS: This single‐center, cross‐sectional retrospective study compared premature ovulation rates and clinical outcomes in I...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Kazuki, Kuroda, Keiji, Horikawa, Takashi, Moriyama, Azusa, Juen, Hiroyasu, Itakura, Akiko, Watanabe, Hideaki, Takamizawa, Satoru, Ojiro, Yuko, Nakagawa, Koji, Sugiyama, Rikikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656665/
https://www.ncbi.nlm.nih.gov/pubmed/34938146
http://dx.doi.org/10.1002/rmb2.12422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656665/
https://www.ncbi.nlm.nih.gov/pubmed/34938146
http://dx.doi.org/10.1002/rmb2.12422

Ejemplares similares